XML 55 R22.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Note 8 - Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2019
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Weighted
Average,
December 31,
2019
   
Range,
December 31,
2019
   
Weighted
Average,
December 31,
2018
   
Range,
December 31,
2018
 
Volatility
   
68
%
 
68
-
70%
 
   
70
%
 
63%
-
76%
 
Dividend yield
   
   
 
 
     
   
 
 
 
Risk-free interest rate
   
1.75
%
 
1.74
1.75%
 
   
2.73
%
 
2.68%
-
2.78%
 
Expected term (years)
   
5.0
   
5.0
to
5.2
     
3.9
   
3.4
to
4.3
 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
   
Options
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2019
   
7,411,600
    $
1.08
     
3.1
    $
20,375
 
Granted
   
390,000
     
0.60
     
 
     
 
 
Exercised
   
-
     
-
     
 
     
 
 
Forfeited
   
-
     
-
     
 
     
 
 
Expired
   
-
     
-
     
 
     
 
 
Outstanding at December 31, 2019
   
7,801,600
    $
1.06
     
2.8
    $
-
 
Exercisable at December 31, 2019
   
7,801,600
    $
1.06
     
2.8
    $
-
 
Schedule of Nonvested Share Activity [Table Text Block]
   
Options
   
Weighted Average
Grant-Date Fair
Value
 
Nonvested at July 1, 2019
   
-
    $
-
 
Granted
   
390,000
     
0.26
 
Vested
   
(390,000
)    
0.26
 
Nonvested at December 31, 2019
   
    $
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   
Three
months
ended
December 31,
2019
   
Three
months
ended
December 31,
2018
   
Six months
ended
December 31,
2019
   
Six months
ended
December 31,
2018
 
General and administrative:
                               
Change in fair value from modification of option terms
  $
-
    $
-
    $
-
    $
211,185
 
Change in fair value from modification of warrant terms
   
-
     
-
     
-
     
118,233
 
Fair value of stock options expensed
   
92,000
     
22,500
     
92,000
     
92,125
 
Total
  $
92,000
    $
22,500
    $
92,000
    $
421,543
 
                                 
Research and development:
                               
Change in fair value from modification of option terms
  $
-
    $
-
    $
-
     
11,115
 
Change in fair value from modification of warrant terms
   
-
     
-
     
-
     
44,793
 
Fair value of stock options expensed
   
7,500
     
-
     
7,500
     
25,875
 
Total
  $
7,500
    $
-
    $
7,500
    $
81,783